Antitrust Antitrust

King, Lexon, Alissa used messaging and hotel meetup to share drug data, says UK CMA

By Simon Zekaria
  • 25 Jun 2020 08:41
  • 25 Jun 2020 08:53

King Pharmaceuticals, Lexon and Alissa Healthcare covertly shared sensitive data through messages and a hotel meeting to skew the UK drugs market and maintain high prices of antidepressant drug nortriptyline, the Competition and Markets Authority has said today.

< The CMA had already fined the companies a total of 3.4 million pounds<

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Simon Zekaria

Senior Correspondent

Simon Zekaria is a senior correspondent in London, covering UK regulation. Prior to joining MLex, Simon reported on business news for The Wall Street Journal, including on telecommunications, media, technology and consumer affairs. Simon was also a writer for the WSJ on diverse subjects such as Brexit, UK politics and global sport. Simon was previously a correspondent on competition issues and European politics for Thomson Reuters and Agence France-Presse in Brussels. Simon is a graduate of Edinburgh University, with Masters degrees in literature and law. A French speaker, he has studied at the Sorbonne University, Paris.

Discover MLex

Stay on top of global regulatory developments

Latest News